Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-02-22 @ 9:37 AM
Study NCT ID:
NCT00110851
Status:
COMPLETED
Last Update Posted:
2007-08-23
First Post:
2005-05-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)
Sponsor:
Wellstat Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PN2034.05.001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None